Inovio Pharmaceuticals Ownership | Who Owns Inovio Pharmaceuticals?


OverviewForecastFinancialsChartTranscripts

Inovio Pharmaceuticals Ownership Summary


Inovio Pharmaceuticals is owned by 0.93% institutional investors, 0.42% insiders, and 98.66% retail investors. Vanguard group is the largest institutional shareholder, holding 6.36% of INO shares. Fidelity Small Cap Growth is the top mutual fund, with 7.33% of its assets in Inovio Pharmaceuticals shares.

INO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockInovio Pharmaceuticals0.93%0.42%98.66%
SectorHealthcare Stocks 35.49%11.75%52.76%
IndustryBiotech Stocks 34.83%11.71%53.46%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group3.32M6.36%$5.77M
Fmr9.34M1.99%$16.25M
Janus henderson group3.31M0.71%$5.77M
Boxer capital management2.37M0.51%$4.12M
D. e. shaw2.21M0.47%$3.85M
Millennium management1.41M0.30%$2.45M
Two sigma advisers, lp108.70K0.28%$254.36K
Eversept partners, lp1.04M0.22%$1.80M
Adage capital partners gp804.96K0.17%$1.40M
Geode capital management801.50K0.17%$1.40M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Boxer capital management2.37M0.54%$4.12M
Diadema partners lp562.66K0.17%$979.04K
Green alpha advisors65.58K0.11%$114.11K
Eversept partners, lp1.04M0.10%$1.80M
Persistent asset partners142.16K0.09%$247.37K
Gsa capital partners llp265.07K0.03%$461.00K
683 capital management248.79K0.02%$432.89K
Diametric capital, lp24.49K0.01%$42.61K
Gmt capital126.12K0.01%$219.45K
Nine masts capital26.32K0.01%$45.79K

Top Buyers

HolderShares% AssetsChange
Eversept partners, lp1.04M0.10%1.04M
Vanguard group3.32M0.00%602.71K
Vanguard fiduciary trust392.07K0.00%392.07K
Citadel advisors286.35K0.00%286.35K
Gmt capital126.12K0.01%126.12K

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp---1.98M
Adage capital partners gp804.96K0.00%-1.75M
Aigh capital management---654.12K
Stonepine capital management---518.33K
Fmr9.34M0.00%-507.05K

New Positions

HolderShares% AssetsChangeValue
Eversept partners, lp1.04M0.10%1.04M$1.80M
Vanguard fiduciary trust392.07K0.00%392.07K$682.20K
Two sigma advisers, lp108.70K0.00%108.70K$254.36K
Tower research capital llc (trc)55.49K0.00%55.49K$96.55K
Imc-chicago37.89K-37.89K$65.93M

Sold Out

HolderChange
Ameritas advisory services-2.00
Sachetta-3.00
Johnson financial group-4.00
S&t bank/pa-4.00
Cbiz investment advisory services-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202655-48.11%4,340,403-86.86%-0.02%16-62.79%9-62.50%
Dec 31, 202567-35.58%6,818,031-67.10%130.46%21-58.82%15-31.82%
Sep 30, 202599-1.00%20,701,614120.05%539.08%498.89%20-25.93%
Jun 30, 2025106-1.85%10,167,785-25.24%262.11%47-9.62%293.57%
Mar 31, 20251081.89%13,600,9321.91%351.57%53-8.62%2780.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Small Cap Growth5.98M7.33%-
Fidelity Small Cap Growth K62.98M3.66%-
Vanguard Total Stock Mkt Idx Inv2.08M3.00%-
Vanguard US Total Market Shares ETF818.82K2.23%-
Fidelity Advisor Biotechnology I883.08K1.08%-
Vanguard Institutional Extnd Mkt Idx Tr738.66K1.06%-
iShares Russell 2000 Value ETF324.75K0.89%-
Fidelity Small Cap Index377.40K0.74%-15.86K
Vanguard Russell 2000 ETF180.62K0.49%1.64K
Vanguard Strategic Equity Inv250.14K0.49%-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 05, 2023Zoth Lota S.-Sell$3.19K
Mar 13, 2023Weiner David B.-Sell$6.71K
Feb 27, 2023Weiner David B.-Sell$14.94K
Aug 11, 2022Weiner David B. Sell$31.59K
Jul 20, 2022BENITO SIMON X Sell$4.50K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q2--

INO Ownership FAQ


Who Owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals shareholders are primarily institutional investors at 0.93%, followed by 0.42% insiders and 98.65% retail investors. The average institutional ownership in Inovio Pharmaceuticals's industry, Biotech Stocks , is 34.83%, which Inovio Pharmaceuticals falls below.

Who owns the most shares of Inovio Pharmaceuticals?

Inovio Pharmaceuticals’s largest shareholders are Vanguard group (3.32M shares, 6.36%), Fmr (9.34M shares, 1.99%), and Janus henderson group (3.31M shares, 0.71%). Together, they hold 9.05% of Inovio Pharmaceuticals’s total shares outstanding.

Does Blackrock own Inovio Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Inovio Pharmaceuticals.

Who is Inovio Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Boxer capital management is Inovio Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.54% of its assets in 2.37M Inovio Pharmaceuticals shares, valued at 4.12M$.

Who is the top mutual fund holder of Inovio Pharmaceuticals shares?

Fidelity Small Cap Growth is the top mutual fund holder of Inovio Pharmaceuticals shares, with 7.33% of its total shares outstanding invested in 5.98M Inovio Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools